Establishing Clear Regulatory Pathways for Nanomedicines
The regulatory evaluation of nanomedicines, including targeted liposomes, presents a unique challenge to authorities like the Central Drugs Standard Control Organisation (CDSCO) in India. Unlike conventional drugs, nanomedicines require evaluation of not just the active ingredient, but also the physical and chemical properties of the...